NASDAQ:BCPC

Balchem (BCPC) Stock Price, News & Analysis

$144.48
+0.76 (+0.53%)
(As of 11:01 AM ET)
Today's Range
$143.36
$144.88
50-Day Range
$140.58
$157.27
52-Week Range
$110.74
$159.52
Volume
3,600 shs
Average Volume
103,158 shs
Market Capitalization
$4.66 billion
P/E Ratio
43.13
Dividend Yield
0.55%
Price Target
$135.00

Balchem MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
6.1% Downside
$135.00 Price Target
Short Interest
Healthy
1.12% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.54
Upright™ Environmental Score
News Sentiment
0.98mentions of Balchem in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$11.84 M Sold Last Quarter
Proj. Earnings Growth
12.08%
From $4.14 to $4.64 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.28 out of 5 stars

Basic Materials Sector

26th out of 173 stocks

Chemicals & Allied Products Industry

4th out of 16 stocks

BCPC stock logo

About Balchem Stock (NASDAQ:BCPC)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

BCPC Stock Price History

BCPC Stock News Headlines

This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Balchem Corp
BCPC Apr 2024 165.000 call
This Apple-like Innovator is Revolutionizing Healthcare
AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.
Balchem: Potential Turnaround Is In The Price
BCPC Mar 2024 150.000 call
Balchem Full Year 2023 Earnings: EPS Misses Expectations
BCPC Mar 2024 175.000 call
BCPC Mar 2024 145.000 call
Balchem Q4 2023 Earnings Preview
See More Headlines
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/16/2024
Today
4/23/2024
Next Earnings (Confirmed)
5/03/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
CUSIP
05766520
CIK
9326
Employees
1,302
Year Founded
1967

Price Target and Rating

Average Stock Price Target
$135.00
High Stock Price Target
$135.00
Low Stock Price Target
$135.00
Potential Upside/Downside
-6.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$108.54 million
Pretax Margin
14.88%

Debt

Sales & Book Value

Annual Sales
$922.44 million
Cash Flow
$5.08 per share
Book Value
$32.69 per share

Miscellaneous

Free Float
31,696,000
Market Cap
$4.64 billion
Optionable
Optionable
Beta
0.71

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Theodore L. Harris (Age 59)
    Chairman, CEO & President
    Comp: $2.33M
  • Mr. Carl Martin Bengtsson (Age 46)
    Executive VP, CFO & Treasurer
    Comp: $864.13k
  • Ms. Hatsuki Miyata (Age 48)
    Executive VP, General Counsel & Secretary
    Comp: $618.21k
  • Mr. Jonathan H. Griffin (Age 48)
    Senior VP and GM of Animal Nutrition & Health
    Comp: $624.01k
  • Mr. Martin Luther Reid (Age 56)
    Senior VP & Chief Supply Chain Officer
    Comp: $672.26k
  • Mr. William A. Backus CPA (Age 58)
    VP & Chief Accounting Officer
    Comp: $560.79k
  • Mr. Michael R. Sestrick Ph.D. (Age 60)
    Senior VP & CTO
  • Mr. M. Brent Tignor (Age 45)
    Senior VP & Chief Human Resources Officer
  • Mr. Frederic Boned (Age 46)
    Senior VP and GM of Human Nutrition & Health
  • Mr. Job L. van Gunsteren (Age 48)
    Senior VP & GM of Specialty Products

BCPC Stock Analysis - Frequently Asked Questions

Should I buy or sell Balchem stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings
or view top-rated stocks.

What is Balchem's stock price target for 2024?

1 analysts have issued 12 month price targets for Balchem's stock. Their BCPC share price targets range from $135.00 to $135.00. On average, they predict the company's stock price to reach $135.00 in the next twelve months. This suggests that the stock has a possible downside of 6.1%.
View analysts price targets for BCPC
or view top-rated stocks among Wall Street analysts.

How have BCPC shares performed in 2024?

Balchem's stock was trading at $148.75 at the beginning of 2024. Since then, BCPC shares have decreased by 3.4% and is now trading at $143.72.
View the best growth stocks for 2024 here
.

When is Balchem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 3rd 2024.
View our BCPC earnings forecast
.

How can I listen to Balchem's earnings call?

Balchem will be holding an earnings conference call on Friday, May 3rd at 11:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13745950".

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) issued its quarterly earnings results on Friday, February, 16th. The basic materials company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.02. The basic materials company earned $228.70 million during the quarter, compared to analyst estimates of $234.66 million. Balchem had a trailing twelve-month return on equity of 10.69% and a net margin of 11.77%. The company's revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 earnings per share.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem declared an annual dividend on Monday, December 4th. Stockholders of record on Wednesday, December 27th will be given a dividend of $0.79 per share on Friday, January 19th. This represents a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 26th. This is a positive change from the stock's previous annual dividend of $0.40.
Read our dividend analysis for BCPC
.

Is Balchem a good dividend stock?

Balchem (NASDAQ:BCPC) pays an annual dividend of $0.79 per share and currently has a dividend yield of 0.55%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 23.58%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 17.03% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.

What is Dino A. Rossi's approval rating as Balchem's CEO?

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).

Who are Balchem's major shareholders?

Balchem's stock is owned by many different retail and institutional investors. Top institutional investors include Wasatch Advisors LP (5.83%), Congress Asset Management Co. MA (0.80%), Tributary Capital Management LLC (0.42%), Allspring Global Investments Holdings LLC (0.26%), Raymond James & Associates (0.15%) and Congress Wealth Management LLC DE (0.13%). Insiders that own company stock include David B Fischer, Gunsteren Job Leonard Van, Michael Robert Sestrick, Theodore L Harris and William A Backus.
View institutional ownership trends
.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Balchem have any subsidiaries?
The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc..
Read More
This page (NASDAQ:BCPC) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners